Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
May 23, 2019 8:30 AM EDT
20ᵀᴴ Annual B. Riley FBR Institutional Investor Conference
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will participate in a fireside chat presentation with Mayank Mamtani, B. Riley FBR research analyst
Beverly Hills
Archived Events
Date Event Details
Nov 13, 2016
The Liver Meeting® 2016, the Annual Meeting of the American Association for the Study of Liver Disease
Boston

RNA interference therapeutic ARC-AAT prevents production of Z-alpha1 antitrypsin polymers and reverses liver disease phenotype in PiZ mouse model

  • Publication Number: 124
  • Session: Parallel 19: Pediatric and Metabolic Liver Diseases: Basic and Translational
  • Session Date and Time: November 13, 2016 from 4:45 PM to 6:15 PM
  • Authors: Christine Wooddell, et al.

RNA interference (RNAi) with ARC-AAT provides deep and prolonged knockdown of alpha-1 antitrypsin levels in healthy volunteers

  • Publication Number: LB-24
  • Session: Late-Breaking Poster Session
  • Session Date and Time: November 13, 2016 from 8:00 AM to 5:30 PM

Authors: Alice Turner, et al.

Nov 7, 2016 11:30 AM MST
The 25th Annual Credit Suisse Healthcare Conference
Scottsdale, AZ

November 7, 11:30 a.m. MST – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation.

Sep 29, 2016 6:00 AM PDT
Arrowhead/Amgen Collaboration Call
Sep 23, 2016 7:30 PM EDT
2016 International HBV Meeting
Seoul, Korea

September 24, 8:30 a.m. KST – Zhao Xu, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Functional HBsAg-encoding HBV fusion transcripts are produced from integrated HBV DNA in chronically infected chimpanzees - evidence from single molecule, real time (SMRT) sequencing”

Sep 14, 2016 4:30 PM EDT
7th Non-Coding RNA & RNAi Therapeutics Conference
Boston

September 14, 4:30 p.m. EDT – Erik Bush, Ph.D., Arrowhead director of extrahepatic targeting will deliver an oral presentation titled, “Targeted delivery strategies using Dynamic PolyconjugateTM (DPCTM) technology”

Sep 9, 2016 10:00 AM EDT
The 23rd Annual NewsMakers in the Biotech Industry
New York

September 9, 10:00 a.m. EDT – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation

Aug 9, 2016 4:30 PM EDT
Arrowhead Fiscal 2016 Third Quarter Results
Jul 13, 2016 10:45 AM EDT
Cantor Fitzgerald 2nd Annual Healthcare Conference
New York
Jun 10, 2016 10:30 AM EDT
Jefferies 2016 Healthcare Conference
New York
May 28 - May 29, 2016 12:00 AM EDT
5th Asian Conference on Hepatitis and AIDS (ACHA)

May 29, 4:50 p.m. CST (China Standard Tim) – Bruce Given, M.D., Arrowhead chief operating officer will deliver an oral presentation titled, “RNAi therapeutics for chronic HBV - Animal models”